Top compounds associated with response to NAT6


Feature Type Standardized
Nominal ANOVA
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC -0.032 0.4
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC 0.034 0.4
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA KPT185 CTRPv2 pan-cancer AAC 0.034 0.4
mRNA regorafenib CTRPv2 pan-cancer AAC -0.032 0.4
mRNA NVP-231 CTRPv2 pan-cancer AAC 0.028 0.4
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA VER-155008 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA 5-FU CTRPv2 pan-cancer AAC 0.029 0.4
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.045 0.4
Download CSV